Skip to main content

Advertisement

Springer Nature Link
Log in

HSD11B1 gene polymorphisms in type 2 diabetes and metabolic syndrome—Do we have evidence for the association?

  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Diabetes mellitus (DM) is a major health problem, and its prevalence has been rapidly increasing in the last century. Being polygenic in nature, multiple genes are involved in developing type 2 diabetes (T2DM). Genes involved in the cortisol pathway interact to develop metabolic syndrome (metS) and T2DM, and these conditions resemble Cushing’s syndrome caused by excess cortisol activity in the visceral adipose tissue. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 enzyme (11β-HSD1), engaged in the inter-conversion of inert cortisone and active cortisol in metabolically active tissues, is associated with insulin resistance (IR), T2DM, hypertension, and metS. Studies have reported the role of single-nucleotide polymorphisms (SNPs) of the HSD11B1 gene in the susceptibility to metS and T2DM. This review offers an overview of the contribution of common HSD11B1 single-nucleotide variants in the development of T2DM and metS. We conducted a literature survey in PubMed, Medline, Google, and Embrase databases with the belief that they may provide a starting point for further dialog or need to conduct further studies in this area. From this review study, the frequently studied SNPs rs12086634 and rs846910 were found to be associated with T2DM and rs12086634, rs1000283, and rs846910 associates with metS. The SNPs rs12086634 and rs846910 show conflicting association with T2DM and metS in various ethnic populations. Further studies with adequate sample size may be needed to confirm the association of HSD11B1 gene polymorphisms in different populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hertel JK, Johansson S, Midthjell K, Nygard O, Njolstad PR, Molven A. Type 2 diabetes genes—Present status and data from Norwegian studies. Norsk Epidemiologi. 2013;23:9–22.

    Google Scholar 

  2. Smit P, Dekker MJ, de Jong FJ, van den Beld AW, Koper JW, Pols HA, et al. Lack of Association of the 11betahydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia. J Clin Endocrinol Metab. 2007;92:359–62.

    Article  CAS  PubMed  Google Scholar 

  3. Jeong I-K. The role of cortisol in the pathogenesis of the metabolic syndrome. Diabetes Metab J. 2012;36:207–10.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Di Dalmazi G, Pagotto U, Pasquali R, Vicennati V. Glucocorticoids and type 2 diabetes: from physiology to pathology. J Nutr Metab. 2012;2012:1–9.

    Article  Google Scholar 

  5. Michalaki M, Kyriazopoulou V, Antonacopoulou A, Koika V, Nikolaou M, Tsoukas A, et al. The expression of omental 11beta-HSD1 is not increased in severely obese women with metabolic syndrome. Obes Facts. 2012;5:104–11.

    Article  CAS  PubMed  Google Scholar 

  6. Baudrand R, Carvajal CA, Riquelme A, Morales M, Solis N, Pizarro M, et al. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients. Obes Surg. 2010;20:77–83.

    Article  PubMed  Google Scholar 

  7. Baudrand R, Dominguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, et al. Overexpression of hepatic 5alpha-reductase and 11beta-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Metabolism. 2011;60:1775–80.

    Article  CAS  PubMed  Google Scholar 

  8. Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM, et al. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf). 2006;65:81–7.

    Article  CAS  Google Scholar 

  9. Tomlinson JW, Finney J, Gay C, Hughes BA, Hughes SV, Stewart PM. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes. 2008;57:2652–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A, et al. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity. 2006;14:794–8.

    Article  CAS  PubMed  Google Scholar 

  11. Michailidou Z, Jensen MD, Dumesic DA, Chapman KE, Seckl JR, Walker BR, et al. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity. 2007;15:1155–63.

    Article  CAS  PubMed  Google Scholar 

  12. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab. 2002;87:2701–5.

    CAS  PubMed  Google Scholar 

  13. Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response. Ann N Y Acad Sci. 2006;1088:265–73.

    Article  CAS  PubMed  Google Scholar 

  14. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294:2166–70.

    Article  CAS  PubMed  Google Scholar 

  15. Stimson RH, Walker BR. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Minerva Endocrinol. 2007;32:141–59.

    CAS  PubMed  Google Scholar 

  16. Munoz R, Carvajal C, Escalona A, Boza C, Perez G, Ibanez L, et al. 11betahydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients. Obes Surg. 2009;19:764–70.

    Article  PubMed  Google Scholar 

  17. Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA, et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 2003;88:2738–44.

    Article  CAS  PubMed  Google Scholar 

  18. Makkonen J, Westerbacka J, Kolak M, Sutinen J, Corner A, Hamsten A, et al. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. Int J Obes. 2007;31:1617–25.

    Article  CAS  Google Scholar 

  19. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, et al. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia. 2004;47:1088–95.

    Article  CAS  PubMed  Google Scholar 

  20. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994;105:R11–7.

    Article  CAS  PubMed  Google Scholar 

  21. Robitaille J, Brouillette C, Houde A, Despres JP, Tchernof A, Vohl MC. Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome. Obes Res. 2004;12:1570–5.

    Article  CAS  PubMed  Google Scholar 

  22. Ku YH, Koo BK, Kwak SH, Cho YM, Shin HD, Lee HK, et al. Regulatory effect of common promoter polymorphisms on the expression of the 11beta-hydroxysteroid dehydrogenase type 1 gene. Horm Res. 2009;72:25–32.

    Article  CAS  PubMed  Google Scholar 

  23. Gambineri A, Tomassoni F, Munarini A, Stimson RH, Mioni R, Pagotto U, et al. A combination of polymorphisms in HSD11B1 associates with in vivo 11b-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. Eur J Endocrinol. 2011;165:283–92.

    Article  CAS  PubMed  Google Scholar 

  24. Malavasi EL, Kelly V, Nath N, Gambineri A, Dakin RS, Pagotto U, et al. Functional effects of polymorphisms in the human gene encoding 11beta-hydroxysteroid dehydrogenase type 1 (11 beta -HSD1): a sequence variant at the translation start of 11 beta -HSD1 alters enzyme levels. Endocrinology. 2010;151:195–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moon SS, Lee YS, Kim JG, Kim SW, Jeong JY, Jeon EJ, et al. Relationship of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic syndrome and type 2 diabetes. Endocr J. 2011;58:949–59.

    Article  CAS  PubMed  Google Scholar 

  26. Franks PW, Knowler WC, Nair S, Koska J, Lee YH, Lindsay RS, et al. Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension. 2004;44:681–8.

    Article  CAS  PubMed  Google Scholar 

  27. Turek LV, Leite N, Rodrigues Souza RL, Lima JK, Milano GE, Timossi Lda S, et al. Gender-dependent association of HSD11B1 single nucleotide polymorphisms with glucose and HDL-C levels. Genet Mol Biol. 2014;37(3):490–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Uckaya G, Karadurmus N¸ Kutlu O, Corakci A, Kizildag S, et al. Adipose tissue 11-beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008;82:135–40.

    Article  Google Scholar 

  29. Lavery GG, McTernan CL, Bain SC, Chowdhury TA, Hewison M, Stewart PM. Association studies between the HSD11B2 gene (encoding human 11b-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy. Eur J Endocrinol. 2002;146:553–8.

    Article  CAS  PubMed  Google Scholar 

  30. Walker BR, Andrew R. Tissue production of cortisol by 11betahydroxysteroid dehydrogenase type 1 and metabolic disease. Ann N Y Acad Sci. 2006;1083:165–84.

    Article  CAS  PubMed  Google Scholar 

  31. Gandhi K, Adhikari P, Basu A, Achappa B. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a south Indian population. Metab Syndr Relat Disord. 2013;11:397–402.

    Article  CAS  PubMed  Google Scholar 

  32. Miyamoto Y, Morisaki H, Yamanaka I, Kokubo Y, Masuzaki H, Okayama A, et al. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort. Diabetes Res Clin Pract. 2009;85:132–8.

    Article  CAS  PubMed  Google Scholar 

  33. Dujic T, Bego T, Mlinar B, Semiz S, Malenica M, Prnjavorac B, et al. Association between 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population. Biochemia Medica. 2012;22:76–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank the Government of India and Manipal University.

Sources of Support

Research Society for the Study of Diabetes in India and Department of Science and Technology (INSPIRE)

Funding

DST-INSPIRE, RSSDI

Competing interests

The authors declare that they have no conflicts of interest.

Authors’ contributions

Mrs Nayana Devang carried out the literature survey of HSD11B1 gene association studies and drafted the manuscript. Dr. Prabha Adhikari guided in designing the manuscript, tables, and conclusions. Dr. Nandini M. and Dr. Sathish Rao participated in writing the introduction. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

  1. Department of Medicine, Kasturba Medical College, Manipal University, Mangalore, Karnataka, 575001, India

    Nayana Devang, Satish Rao & Prabha Adhikari

  2. Department of Biochemistry, Kasturba Medical College, Manipal University, Mangalore, 575003, India

    Nandini M

Authors
  1. Nayana Devang
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Nandini M
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Satish Rao
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Prabha Adhikari
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Prabha Adhikari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Devang, N., M, N., Rao, S. et al. HSD11B1 gene polymorphisms in type 2 diabetes and metabolic syndrome—Do we have evidence for the association?. Int J Diabetes Dev Ctries 36, 95–102 (2016). https://doi.org/10.1007/s13410-015-0438-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-015-0438-5

Keywords